Company Profile
Endra Stock Price, News & Catalysts
- Ticker:
- NDRA
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
5.88 USD (-1.34%)
Close
Last updated: October 1, 2026
9.32M USD
Market cap
Why the stock is moving
As of Oct 1, 2026, NDRA closed down 1.34% at $5.88. No new same-company headline was identified in the current news window.
Company overview
Liver Imaging Technology Company
ENDRA Life Sciences develops thermoacoustic imaging technology for measuring liver fat. Its TAEUS platform is intended to provide a lower-cost, point-of-care alternative to MRI-based quantification.
TAEUS Liver System
TAEUS uses short radiofrequency pulses to stimulate tissue and ultrasound sensors to detect the resulting acoustic response. The system estimates liver fat fraction without ionizing radiation or contrast agents.
MASLD and MASH Monitoring
Quantitative liver-fat measurement can support detection and longitudinal monitoring of metabolic dysfunction-associated steatotic liver disease. ENDRA aims to place this capability in clinics that already use conventional ultrasound.
Clinical Validation Program
The company has conducted feasibility and repeatability studies comparing TAEUS measurements with MRI proton-density fat fraction. Results are being used to refine the device and design a pivotal U.S. clinical study.
De Novo Regulatory Pathway
ENDRA has engaged with the FDA on device configuration, study design, and a De Novo submission pathway. Clearance would be required before broad commercialization in the United States.
Future catalysts
- Initiation and completion of the pivotal U.S. study intended to support a De Novo submission for TAEUS Liver.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Endra (NDRA)?
Endra (NDRA) most recently closed at 5.88 USD, a -1.34% move versus the previous session.
What is the market cap of Endra (NDRA)?
Endra currently has a market capitalization of 9.32M USD on BioPharmSignal.
What does Endra do?
Liver Imaging Technology Company ENDRA Life Sciences develops thermoacoustic imaging technology for measuring liver fat. Its TAEUS platform is intended to provide a lower-cost, point-of-care alternative to MRI-based quantification. TAEUS Liver System TAEUS uses short radiofrequency pulses to stimulate tissue and ultrasound sensors to detect the resulting...
On which exchange is NDRA stock listed?
Endra (NDRA) is associated with NASDAQ, United States, Biopharma.
What is Liver?
study intended to support a De Novo submission for TAEUS Liver.
Which conditions is Endra targeting with Liver?
Endra is associated with metabolic disease based on its company overview and current catalyst commentary.
How does Endra describe recent progress with Liver?
study intended to support a De Novo submission for TAEUS Liver.
What is Imaging?
Liver Imaging Technology Company ENDRA Life Sciences develops thermoacoustic imaging technology for measuring liver fat.